Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngostenosis | 5 | 2023 | 36 | 0.790 |
Why?
|
| Hypopharynx | 2 | 2016 | 7 | 0.580 |
Why?
|
| Vocal Cord Paralysis | 4 | 2022 | 68 | 0.550 |
Why?
|
| Laryngeal Neoplasms | 5 | 2019 | 79 | 0.550 |
Why?
|
| Polyps | 2 | 2016 | 48 | 0.550 |
Why?
|
| Pharyngeal Diseases | 1 | 2016 | 17 | 0.550 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 35 | 0.530 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2019 | 651 | 0.480 |
Why?
|
| Papilloma | 8 | 2003 | 25 | 0.480 |
Why?
|
| Vocal Cords | 5 | 2022 | 63 | 0.430 |
Why?
|
| Laryngoscopy | 5 | 2021 | 149 | 0.350 |
Why?
|
| Voice Disorders | 3 | 2003 | 18 | 0.330 |
Why?
|
| Laryngoplasty | 2 | 2022 | 25 | 0.320 |
Why?
|
| Zenker Diverticulum | 1 | 2008 | 4 | 0.310 |
Why?
|
| Airway Obstruction | 4 | 2016 | 164 | 0.290 |
Why?
|
| Esophagoscopy | 1 | 2008 | 156 | 0.280 |
Why?
|
| Tracheal Diseases | 2 | 2015 | 15 | 0.280 |
Why?
|
| Respiratory Tract Neoplasms | 5 | 1994 | 13 | 0.230 |
Why?
|
| Bronchial Neoplasms | 2 | 2003 | 15 | 0.230 |
Why?
|
| Tracheal Neoplasms | 2 | 2003 | 21 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 6 | 2002 | 481 | 0.220 |
Why?
|
| Papillomaviridae | 2 | 2003 | 137 | 0.220 |
Why?
|
| Pharyngeal Neoplasms | 3 | 1999 | 26 | 0.210 |
Why?
|
| Aorta, Thoracic | 2 | 2018 | 517 | 0.210 |
Why?
|
| Parkinsonian Disorders | 1 | 2003 | 75 | 0.200 |
Why?
|
| Collagen | 1 | 2003 | 313 | 0.200 |
Why?
|
| Botulinum Toxins | 2 | 1996 | 119 | 0.200 |
Why?
|
| Middle Aged | 27 | 2022 | 25966 | 0.190 |
Why?
|
| Voice Quality | 2 | 2016 | 19 | 0.190 |
Why?
|
| Tracheotomy | 1 | 2001 | 35 | 0.180 |
Why?
|
| Cricoid Cartilage | 1 | 2020 | 16 | 0.170 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 2 | 2018 | 16 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2003 | 617 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 113 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2003 | 1115 | 0.160 |
Why?
|
| Treatment Outcome | 13 | 2023 | 12116 | 0.160 |
Why?
|
| Postoperative Complications | 4 | 2018 | 3011 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2003 | 714 | 0.160 |
Why?
|
| Aged, 80 and over | 8 | 2016 | 6373 | 0.160 |
Why?
|
| Retrospective Studies | 14 | 2023 | 15998 | 0.160 |
Why?
|
| Male | 34 | 2022 | 60040 | 0.150 |
Why?
|
| Mucociliary Clearance | 1 | 1997 | 4 | 0.150 |
Why?
|
| Aged | 17 | 2019 | 19067 | 0.150 |
Why?
|
| Endoscopy | 2 | 2016 | 283 | 0.150 |
Why?
|
| Ethmoid Sinus | 1 | 1997 | 9 | 0.140 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1997 | 15 | 0.140 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1997 | 12 | 0.140 |
Why?
|
| Neurilemmoma | 2 | 1997 | 44 | 0.140 |
Why?
|
| Female | 31 | 2022 | 65444 | 0.130 |
Why?
|
| Verbal Behavior | 1 | 1996 | 52 | 0.130 |
Why?
|
| Tracheostomy | 2 | 2015 | 191 | 0.130 |
Why?
|
| Humans | 46 | 2023 | 123157 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 1999 | 289 | 0.130 |
Why?
|
| Multiple Endocrine Neoplasia | 3 | 1992 | 12 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1213 | 0.130 |
Why?
|
| Disease Management | 1 | 2019 | 515 | 0.130 |
Why?
|
| Osteochondrodysplasias | 1 | 2015 | 68 | 0.120 |
Why?
|
| Critical Care | 1 | 2001 | 645 | 0.120 |
Why?
|
| Adult | 24 | 2021 | 29034 | 0.120 |
Why?
|
| Isotretinoin | 2 | 1994 | 25 | 0.120 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2014 | 10 | 0.120 |
Why?
|
| Larynx | 1 | 2015 | 69 | 0.120 |
Why?
|
| Amyloidosis | 3 | 1992 | 66 | 0.120 |
Why?
|
| Tourette Syndrome | 1 | 1996 | 154 | 0.120 |
Why?
|
| Tracheal Stenosis | 1 | 2014 | 31 | 0.120 |
Why?
|
| Recurrence | 3 | 2021 | 1422 | 0.120 |
Why?
|
| Skin Diseases | 3 | 1992 | 122 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2014 | 2043 | 0.110 |
Why?
|
| Radiotherapy, Conformal | 3 | 2002 | 55 | 0.100 |
Why?
|
| Spasm | 2 | 1990 | 48 | 0.090 |
Why?
|
| Reoperation | 2 | 2020 | 819 | 0.090 |
Why?
|
| Lymphatic Metastasis | 2 | 1990 | 399 | 0.090 |
Why?
|
| Facial Paralysis | 1 | 1990 | 36 | 0.090 |
Why?
|
| Cranial Nerve Diseases | 1 | 1990 | 26 | 0.090 |
Why?
|
| Prospective Studies | 7 | 2023 | 6028 | 0.090 |
Why?
|
| Parotid Neoplasms | 1 | 1990 | 14 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2019 | 3329 | 0.090 |
Why?
|
| Interferon Type I | 3 | 1991 | 107 | 0.080 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2008 | 4 | 0.080 |
Why?
|
| Dystonia | 1 | 1990 | 171 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 5046 | 0.070 |
Why?
|
| Veterans | 1 | 2019 | 1727 | 0.070 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 3660 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2003 | 1683 | 0.070 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1985 | 7 | 0.060 |
Why?
|
| Cranial Nerves | 1 | 1985 | 19 | 0.060 |
Why?
|
| Facial Neoplasms | 1 | 1985 | 19 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 1873 | 0.060 |
Why?
|
| Radiation Injuries | 2 | 2002 | 142 | 0.060 |
Why?
|
| Time Factors | 3 | 2021 | 6204 | 0.050 |
Why?
|
| Injections, Intramuscular | 2 | 1996 | 192 | 0.050 |
Why?
|
| Xerostomia | 1 | 2002 | 9 | 0.050 |
Why?
|
| Adolescent | 10 | 2016 | 19095 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 2 | 2018 | 565 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 238 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 730 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 1240 | 0.050 |
Why?
|
| Angiofibroma | 1 | 2000 | 4 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 10010 | 0.040 |
Why?
|
| Prognosis | 3 | 2019 | 4505 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 477 | 0.040 |
Why?
|
| Paranasal Sinus Diseases | 2 | 1997 | 20 | 0.040 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1999 | 23 | 0.040 |
Why?
|
| Glottis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 1999 | 13 | 0.040 |
Why?
|
| Sinusitis | 1 | 2000 | 117 | 0.040 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1999 | 55 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 240 | 0.040 |
Why?
|
| Melanoma | 1 | 1985 | 823 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 424 | 0.040 |
Why?
|
| Inpatients | 1 | 2022 | 492 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1999 | 162 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 860 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 175 | 0.040 |
Why?
|
| Parotid Gland | 2 | 2002 | 20 | 0.040 |
Why?
|
| Cough | 1 | 1997 | 86 | 0.030 |
Why?
|
| Epithelium | 1 | 1997 | 366 | 0.030 |
Why?
|
| Voice | 1 | 2016 | 13 | 0.030 |
Why?
|
| Child | 10 | 2003 | 24225 | 0.030 |
Why?
|
| Trachea | 1 | 1997 | 201 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 30 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2003 | 13880 | 0.030 |
Why?
|
| Infant | 4 | 2003 | 12339 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1997 | 298 | 0.030 |
Why?
|
| United States | 2 | 2021 | 10629 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 1995 | 52 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1993 | 0.030 |
Why?
|
| Nose Neoplasms | 2 | 2000 | 31 | 0.030 |
Why?
|
| Maxillary Sinus | 1 | 1994 | 14 | 0.030 |
Why?
|
| Enophthalmos | 1 | 1994 | 15 | 0.030 |
Why?
|
| Bone Resorption | 1 | 1994 | 41 | 0.030 |
Why?
|
| Quality of Life | 2 | 2020 | 1932 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 437 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1994 | 73 | 0.030 |
Why?
|
| Thyroid Neoplasms | 2 | 1993 | 197 | 0.030 |
Why?
|
| Carcinoma | 2 | 1993 | 278 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1994 | 671 | 0.020 |
Why?
|
| Radiography | 1 | 1994 | 818 | 0.020 |
Why?
|
| Young Adult | 2 | 2016 | 8865 | 0.020 |
Why?
|
| Radiotherapy Dosage | 2 | 2002 | 185 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3049 | 0.020 |
Why?
|
| Facial Muscles | 1 | 1990 | 33 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1994 | 359 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 1997 | 1259 | 0.020 |
Why?
|
| Electromyography | 1 | 1990 | 161 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 2836 | 0.020 |
Why?
|
| Pedigree | 2 | 1993 | 1582 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4704 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1994 | 1390 | 0.020 |
Why?
|
| Calcitonin | 1 | 1989 | 31 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1994 | 1230 | 0.020 |
Why?
|
| Texas | 1 | 2014 | 3547 | 0.020 |
Why?
|
| Skin | 1 | 1989 | 505 | 0.020 |
Why?
|
| Melanocytes | 1 | 1985 | 47 | 0.020 |
Why?
|
| Schwann Cells | 1 | 1985 | 59 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1985 | 391 | 0.020 |
Why?
|
| Biopsy | 1 | 1989 | 1239 | 0.020 |
Why?
|
| Interferons | 1 | 1983 | 124 | 0.010 |
Why?
|
| Remission Induction | 1 | 1991 | 300 | 0.010 |
Why?
|
| Nasal Polyps | 1 | 2000 | 24 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2000 | 57 | 0.010 |
Why?
|
| Antibodies | 1 | 1991 | 370 | 0.010 |
Why?
|
| Immobilization | 1 | 1999 | 23 | 0.010 |
Why?
|
| Technology, Radiologic | 1 | 1999 | 11 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 68 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1999 | 229 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2000 | 601 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1999 | 138 | 0.010 |
Why?
|
| Hospitals, Voluntary | 1 | 1997 | 4 | 0.010 |
Why?
|
| Random Allocation | 2 | 1988 | 423 | 0.010 |
Why?
|
| Hospital Charges | 1 | 1997 | 61 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1999 | 752 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1167 | 0.010 |
Why?
|
| Hospital Costs | 1 | 1997 | 178 | 0.010 |
Why?
|
| Ploidies | 1 | 1995 | 37 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1995 | 25 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 300 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1994 | 54 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1988 | 1089 | 0.010 |
Why?
|
| Orbit | 1 | 1994 | 102 | 0.010 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 1993 | 6 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1995 | 803 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1994 | 221 | 0.010 |
Why?
|
| Genes | 1 | 1993 | 444 | 0.010 |
Why?
|
| Syndrome | 1 | 1994 | 1114 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1993 | 609 | 0.010 |
Why?
|
| Meige Syndrome | 1 | 1990 | 8 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1989 | 33 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1994 | 1387 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1990 | 89 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1989 | 63 | 0.010 |
Why?
|
| Tremor | 1 | 1990 | 129 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1995 | 1432 | 0.000 |
Why?
|
| DNA | 1 | 1993 | 1592 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 396 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1988 | 477 | 0.000 |
Why?
|
| Adenoma, Pleomorphic | 1 | 1985 | 4 | 0.000 |
Why?
|
| Neurofibroma | 1 | 1985 | 6 | 0.000 |
Why?
|
| Paraganglioma | 1 | 1985 | 18 | 0.000 |
Why?
|
| Laser Therapy | 1 | 1988 | 246 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 215 | 0.000 |
Why?
|
| Drug Compounding | 1 | 1983 | 34 | 0.000 |
Why?
|
| Lymphoma | 1 | 1985 | 322 | 0.000 |
Why?
|